Northwestern Mutual Wealth Management’s Minerva Neurosciences NERV Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$602	Hold	100	–	–	﹤0.01%	3829
2025 Q4	$402	Hold	100	–	–	﹤0.01%	3745
2025 Q3	$211	Hold	100	–	–	﹤0.01%	3691
2025 Q2	$172	Hold	100	–	–	﹤0.01%	3522
2025 Q1	$170	Hold	100	–	–	﹤0.01%	3466
2024 Q4	$222	Hold	100	–	–	﹤0.01%	3446
2024 Q3	$267	Hold	100	–	–	﹤0.01%	3413
2024 Q2	$319	Hold	100	–	–	﹤0.01%	3325
2024 Q1	$258	Hold	100	–	–	﹤0.01%	3376
2023 Q4	$615	Hold	100	–	–	﹤0.01%	3252
2023 Q3	$690	Hold	100	–	–	﹤0.01%	3084
2023 Q2	$914	Hold	100	–	–	﹤0.01%	3103
2023 Q1	$160	Hold	100	–	–	﹤0.01%	3208
2022 Q4	$159	Hold	100	–	–	﹤0.01%	3198
2022 Q3	$1K	Buy	+100	New	+$592	﹤0.01%	2997

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

SSC

Spruce Street Capital New York $416M AUM

Northwestern Mutual Wealth Management's NERV Position: Q1 2026 in Review

Northwestern Mutual Wealth Management held its Minerva Neurosciences (NERV) position steady in Q1 2026 at 100 shares worth $602. The position accounts for ﹤0.01% of the portfolio, ranked #3829.

Northwestern Mutual Wealth Management first reported a position in NERV in Q3 2022 and has held it in 15 quarters since. The position peaked at $1K in Q3 2022. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

Northwestern Mutual Wealth Management held 100 shares of Minerva Neurosciences worth $602 as of Q1 2026.
Northwestern Mutual Wealth Management left its Minerva Neurosciences share count unchanged in Q1 2026.
Minerva Neurosciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3829 holding.
Northwestern Mutual Wealth Management first reported a position in Minerva Neurosciences in Q3 2022 and has held it in 15 quarters since.
Northwestern Mutual Wealth Management's Minerva Neurosciences position peaked at $1K in Q3 2022.
47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.